A class of drugs commonly used to treat Alzheimer’s disease and other dementias in nursing home residents has been found to slow cognitive decline over a five-year period in patients diagnosed with ...

A comprehensive study spanning a decade shed new light on the treatment of dementia with Lewy bodies (DLB), a condition that significantly impacts older adults. The research, published in Alzheimer’s ...

Lewy body diseases -- Parkinson's disease and dementia with Lewy bodies -- should be defined as neuronal alpha-synuclein disease, not as clinical syndromes, a new position paper proposed. "Parkinson's ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

Lewy body dementia (LBD) is a type of progressive disease that has affected more than a million Americans, according to the Lewy Body Dementia Association. Over time, it destroys brain cells and can ...

While Alzheimer’s disease is the most common type of dementia, there’s another variation that is also relatively prevalent. Lewy body dementia (LBD) affects more than 1 million people in the US. It is ...

Lewy body dementia (LBD) is a type of dementia caused by abnormal protein deposits in the brain, called Lewy bodies. The deposits cause chemical changes in the brain, leading to problems with thinking ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...